LY3556050 + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Chronic Low-back Pain
Conditions
Chronic Low-back Pain
Trial Timeline
May 20, 2021 → Feb 9, 2022
NCT ID
NCT04874636About LY3556050 + Placebo
LY3556050 + Placebo is a phase 2 stage product being developed by Eli Lilly for Chronic Low-back Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT04874636. Target conditions include Chronic Low-back Pain.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (5)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06074562 | Phase 2 | Completed |
| NCT04874636 | Phase 2 | Completed |
| NCT04707157 | Phase 2 | Terminated |
| NCT04627038 | Phase 2 | Completed |
| NCT05341102 | Phase 1 | Completed |
Competing Products
20 competing products in Chronic Low-back Pain